Nuwellis Stock Today
| NUWE Stock | USD 1.16 0.01 0.87% |
PerformanceWeak
| Odds Of DistressVery High
|
Nuwellis is trading at 1.16 as of the 16th of March 2025, a 0.87 percent increase since the beginning of the trading day. The stock's lowest day price was 1.14. Nuwellis has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Nuwellis operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. The company has 4.37 M outstanding shares of which 264.16 K shares are now shorted by private and institutional investors with about 0.21 trading days to cover. More on Nuwellis
Moving against Nuwellis Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Nuwellis Stock Highlights
| CEO President | Nestor Jaramillo |
| Thematic Idea | Medical Equipment (View all Themes) |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Medical Equipment, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) |
| Financial Strength | |
Nuwellis (NUWE) is traded on NASDAQ Exchange in USA. It is located in 12988 Valley View Road, Eden Prairie, MN, United States, 55344 and employs 59 people. Nuwellis is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.07 M. Nuwellis conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 4.37 M outstanding shares of which 264.16 K shares are now shorted by private and institutional investors with about 0.21 trading days to cover.
Nuwellis currently holds about 12.05 M in cash with (9.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.38.
Check Nuwellis Probability Of Bankruptcy
Ownership AllocationRoughly 97.44 % of Nuwellis outstanding shares are held by general public with 0.68 pct. owned by insiders and only 1.88 % by institutional investors.
Check Nuwellis Ownership Details
Nuwellis Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Nuwellis market risk premium is the additional return an investor will receive from holding Nuwellis long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.0225 | |||
| Jensen Alpha | 0.1175 | |||
| Total Risk Alpha | 0.6949 | |||
| Sortino Ratio | 0.0351 |
Nuwellis Stock Against Markets
Nuwellis Corporate Management
| Neil Esq | General VP | Profile | |
| Robert Scott | Chief Officer | Profile | |
| Laurent Duhoux | VP Devel | Profile | |
| Rob Scott | Director Officer | Profile | |
| William MD | VP Marketing | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuwellis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuwellis. If investors know Nuwellis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuwellis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nuwellis is measured differently than its book value, which is the value of Nuwellis that is recorded on the company's balance sheet. Investors also form their own opinion of Nuwellis' value that differs from its market value or its book value, called intrinsic value, which is Nuwellis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuwellis' market value can be influenced by many factors that don't directly affect Nuwellis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuwellis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuwellis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuwellis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.